Virbac S.A.
VIRP
Rank in Stocks
#4660
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Share Price
$388.56
Market Cap
$3.26B
Change (1 day)
-5.05%
Change (1 year)
-5.77%
Country
FR
Trade Virbac S.A. (VIRP)
Category
Healthcare
Revenue for Virbac S.A. (VIRP)
Revenue in Jun 2026 TTM: $1.77B
According to Virbac S.A. latest financial reports the company's current revenue (TTM) is $1.77B. In 2023 the company made a revenue of $1.38B an increase over the revenue in the year 2022 that was $1.30B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Virbac S.A. from 2002 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.77B | 21.90% |
| 2024 | $1.45B | 5.49% |
| 2023 | $1.38B | 5.66% |
| 2022 | $1.30B | 7.83% |
| 2021 | $1.21B | 6.34% |
| 2020 | $1.14B | 8.07% |
| 2019 | $1.05B | 5.44% |
| 2018 | $998.54M | -3.45% |
| 2017 | $1.03B | 12.74% |
| 2016 | $917.32M | -0.92% |
| 2015 | $925.80M | -1.03% |
| 2014 | $935.43M | -7.59% |
| 2013 | $1.01B | 10.39% |
| 2012 | $916.98M | 13.69% |
| 2011 | $806.57M | 5.31% |
| 2010 | $765.86M | 14.27% |
| 2009 | $670.22M | 8.47% |
| 2008 | $617.87M | -3.61% |
| 2007 | $641.03M | 21.30% |
| 2006 | $528.47M | 20.10% |
| 2005 | $440.02M | -7.65% |
| 2004 | $476.49M | 6.66% |
| 2003 | $446.73M | 15.70% |
| 2002 | $386.10M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $79.67B | 4,394.46% |
US
|
|
| $99.34B | 5,504.13% |
US
|
|
| $64.39B | 3,532.43% |
US
|
|
| $66.40B | 3,646.05% |
US
|
|
| $77.52B | 4,273.32% |
CH
|
